Mr. Thiel has already helped advance Jim O’Neil, managing director at Silicon Valley late-stage venture firm Mithril Capital Management — headed by Mr. Thiel — to lead the Food and Drug Administration. Mr. Thiel has also been discussing potential appointments with other individuals in a variety of health and science roles. STAT reports he spoke with Elias Zerhouni, a former director of the National Institutes of Health and president of global research and development at drugmaker Sanofi, about a key science job in the White House.
He has also spoken to organizations that are promoting possible candidates, including FasterCures, Research!America and the Coalition for Life Sciences, according to the report.
“He’s got pretty broad influence,” said one individual close to the transition team, who chose to remain anonymous, according to the report. The individual added that Mr. Thiel is primarily focused on positions in the FDA, NIH, HHS and the Office of Science and Technology Policy.
Neither representatives for Mr. Thiel nor members of Mr. Trump’s transition team responded to request for comment, STAT reported.
More articles on leadership:
Key trends and concepts about population health for physicians
Trump interviews Cleveland Clinic CEO Dr. Toby Cosgrove for VA job
Why people skills matter again
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
